Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-26 · accession 0001628280-25-008262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-26 | 2025-02-26 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | F - Tax | $39.48 | -2,885 | 13.9K | -17% | -$113.9K |
| DM | 2025-02-26 | 2025-02-26 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | +5,760 | 14.9K | +63% | $0 |
| DM | 2025-02-26 | 2025-02-26 | SUPN | Mottola Frank | SVP, Quality, GMP, Ops, IT | M - OptEx | $0.00 | -5,760 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-26 | F | D | 1,909 | $39.48 | 15,774 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 2 | Common | Common Stock | 2025-02-26 | M | A | 3,750 | $0.00 | 17,683 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-26 | F | D | 976 | $39.48 | 13,933 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| 4 | Common | Common Stock | 2025-02-26 | M | A | 2,010 | $0.00 | 14,909 | D | — | — | |
| 5 | Derivative | Performance Share Units | 2025-02-26 | M | D | 3,750 | $0.00 | 0 | D | $0.00 · — to — | 3,750 Common Stock | (F3) On February 23, 2023, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023. |
| 6 | Derivative | Performance Share Units | 2025-02-26 | M | D | 2,010 | $0.00 | 0 | D | $0.00 · — to — | 2,010 Common Stock | (F2) On February 22, 2022, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022. |